20696817

Source:http://linkedlifedata.com/resource/pubmed/id/20696817

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007134, umls-concept:C0087111, umls-concept:C0205179, umls-concept:C0205210, umls-concept:C0599894, umls-concept:C1268567, umls-concept:C1274040, umls-concept:C1521840, umls-concept:C1527144, umls-concept:C2757011
pubmed:issue	12
pubmed:dateCreated	2010-11-29
pubmed:abstractText	We retrospectively analyzed our patients with advanced renal cell carcinoma who underwent presurgical targeted therapy with tyrosine kinase inhibitors to clarify the safety and clinical benefit. The histopathological effect of this treatment was also examined.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0313225
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Benzenesulfonates, http://linkedlifedata.com/resource/pubmed/chemical/Indoles, http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Protein-Tyrosine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Pyridines, http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles, http://linkedlifedata.com/resource/pubmed/chemical/sorafenib, http://linkedlifedata.com/resource/pubmed/chemical/sunitinib
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	1465-3621
pubmed:author	pubmed-author:HashimotoYasunobuY, pubmed-author:IizukaJunpeiJ, pubmed-author:KobayashiHirohitoH, pubmed-author:KondoTsunenoriT, pubmed-author:NakanoMasahiroM, pubmed-author:NishikawaToshioT, pubmed-author:TanabeKazunariK
pubmed:issnType	Electronic
pubmed:volume	40
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1173-9
pubmed:meshHeading	pubmed-meshheading:20696817-Adult, pubmed-meshheading:20696817-Aged, pubmed-meshheading:20696817-Antineoplastic Agents, pubmed-meshheading:20696817-Benzenesulfonates, pubmed-meshheading:20696817-Carcinoma, Renal Cell, pubmed-meshheading:20696817-Chemotherapy, Adjuvant, pubmed-meshheading:20696817-Female, pubmed-meshheading:20696817-Humans, pubmed-meshheading:20696817-Indoles, pubmed-meshheading:20696817-Kidney Neoplasms, pubmed-meshheading:20696817-Male, pubmed-meshheading:20696817-Middle Aged, pubmed-meshheading:20696817-Molecular Targeted Therapy, pubmed-meshheading:20696817-Neoadjuvant Therapy, pubmed-meshheading:20696817-Neoplasm Staging, pubmed-meshheading:20696817-Protein Kinase Inhibitors, pubmed-meshheading:20696817-Protein-Tyrosine Kinases, pubmed-meshheading:20696817-Pyridines, pubmed-meshheading:20696817-Pyrroles, pubmed-meshheading:20696817-Retrospective Studies, pubmed-meshheading:20696817-Treatment Outcome
pubmed:year	2010
pubmed:articleTitle	Presurgical targeted therapy with tyrosine kinase inhibitors for advanced renal cell carcinoma: clinical results and histopathological therapeutic effects.
pubmed:affiliation	Department of Urology, Tokyo Women's Medical University, 8-1, Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan. tkondo@kc.twmu.ac.jp
pubmed:publicationType	Journal Article